Related Experiment Video
Updated: Aug 29, 2026
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a
Antje Diestel1, Orhan Aktas, Dagmar Hackel
1Department of Cell and Neurobiology, Institute of Anatomy, University Hospital Charité, Berlin, Germany.
Abstract:
Multiple sclerosis (MS) is a chronic demyelinating disease in which it has only recently been suggested that damage to neuronal structures plays a key role. Here, we uncovered a link between the release of lipid breakdown products, found in the brain and cerebrospinal fluid (CSF) of MS patients as well as in experimental autoimmune encephalomyelitis, and neuronal damage mediated by microglial activation. The concentrations of the breakdown product 7-ketocholesterol detected in the CSF of MS patients were capable of inducing neuronal damage via the activation and migration of microglial cells in living brain tissue. 7-ketocholesterol rapidly entered the nucleus and activated poly(ADP-ribose)-polymerase (PARP)-1, followed by the expression of migration-regulating integrins CD11a and intercellular adhesion molecule 1. These findings reveal a novel mechanism linking demyelination and progressive neuronal damage, which might represent an underlying insidious process driving disease beyond a primary white matter phenomenon and rendering the microglial PARP-1 a possible antiinflammatory therapeutic target.
Insights
Researchers found that 7-ketocholesterol, a lipid breakdown product in multiple sclerosis (MS) patients, causes neuronal damage by activating microglial cells. This discovery highlights a new mechanism in MS progression and suggests targeting microglial poly(ADP-ribose)-polymerase-1 (PARP-1) for anti-inflammatory therapy.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Multiple sclerosis (MS) is a chronic demyelinating disease.
- Neuronal damage is increasingly recognized as a key factor in MS pathology.
Purpose of the Study:
- To investigate the link between lipid breakdown products and neuronal damage in MS.
- To identify the mechanism by which these products induce damage.
Main Methods:
- Analysis of cerebrospinal fluid (CSF) from MS patients and experimental autoimmune encephalomyelitis (EAE) models.
- In vivo studies of microglial activation and neuronal damage.
- Molecular analysis of 7-ketocholesterol's effects on microglial cells.
Main Results:
- Elevated levels of 7-ketocholesterol were found in the CSF of MS patients.
- 7-ketocholesterol induced neuronal damage by activating and migrating microglial cells.
- 7-ketocholesterol activated poly(ADP-ribose)-polymerase-1 (PARP-1) in microglia, leading to the expression of CD11a and intercellular adhesion molecule 1.
Conclusions:
- A novel mechanism links demyelination and progressive neuronal damage in MS via 7-ketocholesterol.
- Microglial PARP-1 activation plays a critical role in this process.
- Microglial PARP-1 represents a potential therapeutic target for anti-inflammatory treatment in MS.
